XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating Expenses        
Research and development $ 1,769,339 $ 1,468,441 $ 4,774,534 $ 4,546,746
Sales and marketing 139,751 100,203 389,469 245,364
General and administrative 1,346,360 1,071,889 4,083,572 2,920,815
Total operating expenses 3,255,450 2,640,533 9,247,575 7,712,925
Operating loss (3,255,450) (2,640,533) (9,247,575) (7,712,925)
Other Expenses        
Amortization of debt discount 0 (728,417) (232,426) (728,417)
Other income (expense) (2,621) (44,612) 5,261 (55,328)
Total other expenses (2,621) (773,029) (227,165) (783,745)
Loss from operations before income taxes (3,258,071) (3,413,562) (9,474,740) (8,496,670)
Provision for income taxes 0 0 0 0
Net loss (3,258,071) (3,413,562) (9,474,740) (8,496,670)
Deemed dividend (395,551) 0 (395,551) 0
Net loss attributable to common stockholders $ (3,653,622) $ (3,413,562) $ (9,870,291) $ (8,496,670)
Net loss per share - basic and diluted $ (0.15) $ (0.46) $ (0.41) $ (1.14)
Weighted average common shares - basic and diluted 23,889,591 7,428,788 23,808,012 7,424,713